The moral imperative to continue gene editing research on human embryos
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The publication of the first study to use gene editing techniques in human embryos (Liang et al., 2015) has drawn outrage from many in the scientific community. The prestigious scientific journals Nature and Science have published commentaries which call for this research to be strongly discouraged or halted all together (Lanphier et al., 2015; Baltimore et al., 2015). We believe this should be questioned. There is a moral imperative to continue this research. Gene editing technologies have enormous potential as a therapeutic tool in the fight against disease. Roughly 6% of all births have a serious birth defect, which is genetic or partly genetic in origin (Christianson et al., 2006). Advanced and precise gene editing techniques could virtually eradicate genetic birth defects, thereby benefiting nearly 8 million children every year. In addition 35% of all deaths are due to chronic diseases, such as cancer and diabetes, in those under 70.1 Gene editing could significantly lower this disease burden thereby benefiting billions of people around the world over time. To intentionally refrain from engaging in life-saving research is to be morally responsible for the foreseeable, avoidable deaths of those who could have benefitted (Singer, 1993). Research into gene-editing is not an option, it is a moral necessity. It might be argued that gene editing is unnecessary because couples at risk of having a child with a genetic disorder can use the existing technology of in vitro fertilization (IVF), pre-implantation genetic diagnosis (PGD) and termination of pregnancy (TOP) to ensure that they have a healthy child. Multiple embryos could be created and genetically tested, with only disease-free embryos selected for implantation. This works well for single gene Mendelian disorders like Huntington Disease, cystic fibrosis and thalassaemia. However, the power of PGD for avoiding disease is limited by the number of embryos that can be created. Unless vast numbers of embryos are created, it will not be possible to avoid complex multi-genic disease using PGD. Thus diseases with a polygenic contribution, such as schizophrenia, and common dispositions to diseases will not be addressed by genetic selection without radically increasing the numbers of embryos a couple produces (to hundreds of thousands) (Bourne et al., 2012). Gene editing potentially allows a much wider range of dispositions to disease to be tackled. Furthermore, the power of PGD is also limited by the genetic characteristics of the parents. For instance, in many cases, all embryos produced by a couple will be carriers of the condition that the couple are seeking to avoid passing on. This means that, even if they are able to ‘select’ an unaffected child, the possibility of transmission will arise again at the next generation if a carrier is transferred. By contrast, gene-editing technologies could potentially allow the couple to have a child who does not carry the condition, thus sparing future generations from further gene editing or PGD. However, some in the scientific community are calling a moratorium on gene editing research. Yet, they fail to give a sufficient justification for such a ban. In calling for a moratorium, Lanphier et al. (2015) state: In our view, genome editing in human embryos using current technologies could have unpredictable effects on future generations. This makes it dangerous and ethically unacceptable. Such research could be exploited for non-therapeutic modifications Another relevant example here is IVF and PGD. PGD requires removing two cells from the 8 cell embryo. It excises 1/4 of the embryo. This could have been much more devastating than gene editing yet it has been proven to be safe. Nevertheless, when introduced it was certainly unpredictable what the effects would be for future generations. A further reason given as a justification for moratorium on gene editing research is that it will send us on a slippery slope to non-therapeutic modifications and designer babies. But the mere fact that a technology could be used non-therapeutically doesn’t warrant a moratorium on its use. For example, lasik eye surgery can be used non-therapeutically, but this doesn’t justify restrictions on its therapeutic uses. There would need to be clear evidence that the acceptance of therapeutic lasik will ultimately lead to objectionable non-therapeutic applications. Similarly, IVF and PGD can be used to select for traits like height and intelligence. This doesn’t constitute a good reason not to use these technologies to avoid genetic disease. Rather than a blanket ban on research into gene editing technology, it would be more appropriate to ban the deployment of this technology to enhance normal traits, if that is the concern. Technology can and must be controlled by laws. And if it cannot, there is no point in making laws, including bans. Rather, energy would be better spent preparing to combat the unethical deployment of technology. The clearest
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen, Y., Li, Y., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0153-5 · Cited by 1,135 · cited 2×
“…2 Queensland University of Technology, St Lucia, Brisbane, QLD 4072, Australia & Correspondence: jonathan.pugh@st-annes.ox.ac.uk (J. Pugh) The publication of the first study to use gene editing techniques in human embryos (Liang et al., 2015) has drawn outrage from many in the scientific community.”
BackgroundA prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733 · cited 1×
“The prestigious scientific journals Nature and Science have published commentaries which call for this research to be strongly discouraged or halted all together (Lanphier et al., 2015; Baltimore et al., 2015).”
BackgroundDon’t edit the human germ line
Lanphier, E., Urnov, F., Haecker, S. E., Werner, M., & Smolenski, J. (2015) · Nature · doi:10.1038/519410a · Cited by 530 · cited 2×
“In calling for a moratorium, Lanphier et al. (2015) state: In our view, genome editing in human embryos using current technologies could have unpredictable effects on future generations.”
BackgroundOff-target mutations are rare in Cas9-modified mice
Iyer, V., Shen, B., Zhang, W., Hodgkins, A., Keane, T., Huang, X., & Skarnes, W. C. (2015) · Nature Methods · doi:10.1038/nmeth.3408 · Cited by 185
Cited by
Risks and benefits of human germline genome editing: An ethical analysis
Rubeis, G., & Steger, F. (2018) · Asian Bioethics Review · doi:10.1007/s41649-018-0056-x · Cited by 49
Ranisch, R. (2020) · Bioethics · doi:10.1111/bioe.12635 · Cited by 48
Schleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., Lüneburg, L., Cantz, T., & Heinemann, T. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00487-1 · Cited by 43
Gene Editing, Enhancing and Women’s Role
Simonstein, F. (2019) · Science and Engineering Ethics · doi:10.1007/s11948-017-9875-5 · Cited by 11
Metadata
- Authors
- Savulescu, J., Pugh, J., Douglas, T., & Gyngell, C.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-26
- Volume
- 6
- Issue
- 7
- Pages
- 476-479
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W1826806098
- Cited by
- 131
- References
- 4
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The moral imperative to continue gene editing research on human embryos. https://app.cochat.ai/papers/10.1007/s13238-015-0184-y
- The paper
- Savulescu, J., Pugh, J., Douglas, T., & Gyngell, C. (2015). The moral imperative to continue gene editing research on human embryos. Protein & Cell. https://doi.org/10.1007/s13238-015-0184-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.